Molecular Signatures of Blood Biomarkers in Depression: Gene Expression Analysis of GAR1, PER3, MTPAP, SLC25A26, and CD19, a Case–Control Study
Molekulare Signaturen von Blut-Biomarkern bei Depression: Genexpressionsanalyse von GAR1, PER3, MTPAP, SLC25A26 und CD19, Fall-Kontroll-Studie
Diagnostics · 16.03.2026 · 16 (6) · 884
DOI: 10.3390/diagnostics16060884 ↗Auf einen Blick
Bei 100 unbehandelten MDD-Patient:innen und 100 Kontrollen wurden CD19, MTPAP und PER3 im peripheren Blut erhöht gefunden. Die kombinierte ROC-Analyse ergab eine AUC von 0,885.
Fragestellung
Unterscheidet die Genexpression von CD19, MTPAP, PER3, GAR1 und SLC25A26 im peripheren Blut drug-naïve MDD-Patient:innen von gesunden Kontrollen?
Methode
Fall-Kontroll-Studie; peripheres Blut von 100 neu diagnostizierten, drug-naïven MDD-Patient:innen und 100 alters- und geschlechtsabgeglichenen Kontrollen; qRT-PCR, t-Tests, ANOVA, ROC-Analyse.
Ergebnisse
CD19 (fold change 6,15; p = 6,17 × 10−10), MTPAP (3,99; p = 1,74 × 10−8) und PER3 (2,42; p = 5,33 × 10−6) waren erhöht. GAR1 (1,26; p = 0,47) und SLC25A26 (1,24; p = 0,47) nicht signifikant verändert.
Schlussfolgerung der Autor:innen
Die Autor:innen sehen CD19, MTPAP und PER3 als vielversprechende periphere Blut-Biomarker für MDD mit möglicher Bedeutung für frühe Diagnose, Schweregradeinschätzung und personalisierte Therapie.
Kernaussagen
- CD19, MTPAP und PER3 waren bei MDD erhöht
- Kombinierte ROC-Analyse: AUC 0,885
- Genexpression korrelierte mit HAM-D und PHQ-9
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 16.03.2026. Verfasst von Remya Bhaskaran S und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Sri Ramachandra Institute of Higher Education and Research (SRIHER), Porur, Chennai 600116, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Background/Objective: Major depressive disorder (MDD) is a common mental illness that lacks objective diagnostic biomarkers and has a complicated pathogenesis. Peripheral blood-based gene expression profiling provides a potential, non-invasive method to identify the molecular markers associated with risk stratification and depression severity.This study aimed to investigate the gene expression of five candidate genes—CD19, MTPAP, PER3, GAR1, and SLC25A26—in the peripheral blood of drug-naïve patients with MDD and to evaluate their potential as diagnostic biomarkers.
Methods
Peripheral blood samples were collected from 100 newly diagnosed, drug-naïve MDD patients and 100 age- and sex-matched healthy controls. The total RNA was extracted and reverse-transcribed for quantitative real-time PCR analysis. Fold change and ∆∆Ct values were calculated for each gene, followed by statistical analysis using t-tests and ANOVA. Receiver operating characteristic (ROC) curves were used to evaluate diagnostic performance. Gene co-expression and pathway enrichment analyses were conducted to explore functional relevance.
Results
Significant upregulation was observed for CD19 (fold change = 6.15, p = 6.17 × 10−10), MTPAP (fold change = 3.99, p = 1.74 × 10−8), and PER3 (fold change = 2.42, p = 5.33 × 10−6) in MDD. GAR1 showed modest upregulation (fold change = 1.26, p = 0.47), while SLC25A26 (fold change = 1.24, p = 0.47) was not significantly altered. Combined ROC analysis yielded an AUC of 0.885, indicating a strong discriminative ability. Gene expression correlated with depression severity (HAM-D and PHQ-9).
Conclusions
This study identifies CD19, MTPAP, and PER3 as promising peripheral blood biomarkers for MDD, with potential implications for early diagnosis, severity assessment, and personalized treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Sri Ramachandra Institute of Higher Education and Research (SRIHER), Porur, Chennai 600116, India.
- Department of Psychiatry, Sri Ramachandra Institute of Higher Education and Research (SRIHER), Porur, Chennai 600116, India.
- Department of Human Genetics, Sri Ramachandra Institute of Higher Education and Research (SRIHER), Porur, Chennai 600116, India.
- Dr. RK Diabetic Foot and Podiatric Institute & Rakesh Jhunjhunwala Amputation Prevention Centre, Chennai 600099, India.
ORCID-Profile: Remya Bhaskaran S, Ramya Sugumar
Zitieren
APA
S, R. B., Sugumar, R., Kantipudi, S. J., Priya, C. D. M., & Sasikumar, C. S. (2026). Molecular Signatures of Blood Biomarkers in Depression: Gene Expression Analysis of GAR1, PER3, MTPAP, SLC25A26, and CD19, a Case–Control Study. Diagnostics, 16(6), 884. https://doi.org/10.3390/diagnostics16060884
Vancouver
S RB, Sugumar R, Kantipudi SJ, Priya CDM, Sasikumar CS. Molecular Signatures of Blood Biomarkers in Depression: Gene Expression Analysis of GAR1, PER3, MTPAP, SLC25A26, and CD19, a Case–Control Study. Diagnostics. 2026;16(6):884. doi:10.3390/diagnostics16060884
BibTeX
@article{S2026,
author = {S, Remya Bhaskaran and Sugumar, Ramya and Kantipudi, Suvarna Jyothi and Priya, C D Mohana and Sasikumar, C Sheela},
title = {Molecular Signatures of Blood Biomarkers in Depression: Gene Expression Analysis of GAR1, PER3, MTPAP, SLC25A26, and CD19, a Case–Control Study},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {6},
pages = {884},
doi = {10.3390/diagnostics16060884}
}
EUVIMED